Patient Characteristics
| Patient no. | Age (y) | Sex | Avidity | Concordance | |
|---|---|---|---|---|---|
| 18F-FDG | 89Zr-ss-pertuzumab | ||||
| 1 | 50 | F | Nodal, hepatic, right lung | Nodal, hepatic, right lung | 100% |
| 2 | 48 | F | Osseous | Osseous | 100% |
| 3 | 41 | F | Right breast, nodal, hepatic, osseous | None (interval treatment response) | 0% |
| 4 | 57 | M | Hepatic, osseous | Osseous | 7.4% |
| 5 | 52 | F | Osseous, lung | Solitary osseous (sternum) | 20% |
| 6 | 69 | F | Osseous, nodal | Osseous | 80% |